Christian Loesche,Anna Maria DE VERA JUAREZ,Gerard BRUIN,Farkad Ezzet
申请号：
US16761513
公开号：
US20200277369A1
申请日:
2018.11.11
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present disclosure relates to methods for treating Hidradenitis Suppurativa (HS) using IL-17 antagonists, e. g., secukinumab. Also disclosed herein are IL-17 antagonists, e.g., IL-17 antibodies, such as secukinumab, for treating HS patients, as well as medicaments, dosing regimens, pharmaceutical formulations, dosage forms, and kits for use in the disclosed uses and methods.
